Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
Holding MCK?
Track your performance easily
MCK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$464.42 - $637.51
Previous CloseN/A
Volume137.88K
Average Volume (3M)735.53K
Market Cap
$75.10B
Enterprise Value$69.01B
Total Cash (Recent Filing)$2.78B
Total Debt (Recent Filing)$7.30B
Price to Earnings (P/E)30.7
Beta0.45
Next Earnings
Feb 05, 2025EPS Estimate
8.17Last Dividend Ex-Date
Dec 02, 2024Dividend Yield0.45%
Share Statistics
EPS (TTM)19.29
Shares Outstanding126,940,094
10 Day Avg. Volume705,185
30 Day Avg. Volume735,529
Standard Deviation0.07
R-Squared0.15
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.23
Price to Cash Flow (P/CF)8.90
P/FCF Ratio9.80
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit5.38
Enterprise Value/Ebitda15.60
Forecast
1Y Price Target
$671.00Price Target Upside13.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
McKesson News
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe acquisition of Florida Cancer Specialists is anticipated to positively impact earnings and expand McKesson's US Oncology network.
Earnings GrowthMcKesson is projected to have accelerating organic EBIT growth in most operating segments, including significant growth in U.S. Pharma and Prescription Technology Solutions segments.
Oncology PlatformThe oncology platform includes higher-margin services such as practice management, data analytics, and clinical trial management, making it a key growth engine for McKesson.
Bears Say
Revenue GuidanceThe company reduced its revenue guidance in its Med-Surg business, pointing to normalization of market conditions and lower volumes.
Segment PerformanceThe flu and seasonal illness season is tracking below historical averages, which may weigh on the Med-Surg Solutions segment results.
Share PerformanceDespite recent good news, near-term upside for McKesson shares may be limited due to the 30% rally over the past few months.
---
Ownership Overview
0.08% Insiders
22.50% Mutual Funds
0.77% Other Institutional Investors
56.11% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $464.42 and its highest was $637.51 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $75.10B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Feb 05, 2025 which is in 9 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Nov 06, 2024. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.881 by $0.189.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $2.658 which represents an annual dividend yield of 0.45%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 8.17.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 126,940,094 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $7.07 in its last earnings report, beating expectations of $6.881. Following the earnings report the stock price went up 10.594%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Among the largest hedge funds holding Mckesson Corp.’s share is Brandes Investment Partners LP. It holds Mckesson Corp.’s shares valued at 186M.
---
McKesson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$671.00 (13.43% Upside)
$671.00 (13.43% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 92%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 824.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 2.2%
Last 30 Days ▲ 2.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.54%
12-Months-Change
Fundamentals
Return on Equity
-84.06%
Trailing 12-Months
Asset Growth
9.59%
Trailing 12-Months
Company Description
Mckesson Corp.
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
---
MCK Company Deck
---
MCK Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant revenue and EPS growth, enhanced shareholder returns, and strategic expansions in oncology and biopharma services. However, some concerns remain about the medical segment's performance and margin pressures from GLP-1 products.Read More>---
MCK Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
---
MCK Stock 12 Month Forecast
Average Price Target
$671.00
▲(13.43% Upside)
Technical Analysis
Best Analysts Covering MCK
1 Year
1 Year Success Rate
19/21 ratings generated profit
1 Year Average Return
+30.13%
reiterated a buy rating 4 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +30.13% per trade.
---